Well-Known Cell Protein Reveals New Tricks
News Sep 12, 2012
A protein called “clathrin,” which is found in every human cell and plays a critical role in transporting materials within them, also plays a key role in cell division, according to new research at the University of California, San Francisco.
The discovery, featured on the cover of the Journal of Cell Biology in August, sheds light on the process of cell division and provides a new angle for understanding cancer. Without clathrin, cells divide erratically and unevenly - a phenomenon that is one of the hallmarks of the disease.
“Clathrin is doing more than we thought it was doing,” said Frances Brodsky, DPhil, who led the research.
Brodsky is a professor in the UCSF Department of Bioengineering and Therapeutic Sciences, a joint department of the Schools of Pharmacy and Medicine, and she holds joint appointments in Microbiology and Immunology, as well as Pharmaceutical Chemistry.
A Protein Essential for Transportation in More Than One Route Akin to a three-pronged building block in a child’s construction set, clathrin can provide links to create larger complexes.
When lots of these proteins are assembled together, they can form tough little cages into which cells packs many of their essential biological molecules - hormones, neurotransmitters, membrane proteins and other payloads that need to be transported throughout the cell.
Once thought to be solely involved in transport inside cells, scientists have uncovered more and more of the protein’s hidden functions in the last half-dozen years, including some roles it plays in cell division.
For instance, they learned several years ago about its role in the function of “spindles.” Normally when a cell divides, it forms a spindle by laying down tracks of structural proteins, and uses them as scaffolding to separate the cell’s DNA (in the form of chromosomes) into two equal collections - one identical set of DNA for each of the new daughter cells. Scientists found that clathrin is involved in stabilizing these spindles.
Now, however, Brodsky and her colleagues have shown that clathrin does even more. They deleted clathrin from cells using a technique called RNA interference, which involves infusing in small genetic fragments that block the cell from making the clathrin.
Doing so, Brodsky and her colleagues showed that clathrin stabilizes the structures in dividing cells known as centrosomes.
Tagged with fluorescent chemicals and viewed under a microscope, the centrosomes within a cell that is about to divide look like two glowing eyes peering through the dark. But without clathrin, the team determined, the eyes increase in number.
Brodsky and her colleagues traced this effect to a protein complex formed by one particular component of clathrin called CHC17, which directly stabilizes the centrosome and helps it mature.
Deleting CHC17 or chemically inactivating it, led to cells with a strange appearance. These cells contained multiple, fragmented centrosomes instead of the normal two and built abnormal spindles.
This discovery may reveal pathways towards abnormalities of chromosome segregation associated with cancer, said Brodsky.
The article, “Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG” by Amy B. Foraker, Stéphane M. Camus, Timothy M. Evans, Sophia R. Majeed, Chih-Ying Chen, Sabrina B. Taner, Ivan R. Corrêa Jr., Stephen J. Doxsey and Frances M. Brodsky appears in the August 20, 2012 issue of the Journal of Cell Biology.
Researchers Discover Key Link Between Mitochondria and Cocaine AddictionNews
Researchers were able to block response in mitochondria to cocaine.READ MORE
Insulin Goes Viral: Diabetes and Cancer-causing Mechanisms ExploredNews
Every cell in your body responds to the hormone insulin, and if that process starts to fail, you get diabetes. In an unexpected finding, scientists have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer.READ MORE
Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”News
Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.
Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.
Comments | 0 ADD COMMENT
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018